MedPath

Paracetamol Versus Ibuprofen for PDA Closure

Phase 4
Conditions
Patent Ductus Arteriosus
Interventions
Registration Number
NCT03265782
Lead Sponsor
Ain Shams University
Brief Summary

Comparison between the safety and efficacy of oral paracetamol and oral ibuprofen in treatment of Patent Ductus Arteriosus (PDA) in premature infants

Detailed Description

A pilot study through which we have studied efficacy and safety of oral paracetamol and oral ibuprofen in treatment of hemodyamically significant pda in preterm neonates. 30 preterm neonates were included in the study 15 per each group. echo was done in the beginning and during treatment with both drugs to follow up the closure of the duct.

Ibuprofen was given as 10 mg/kg/dose in the 1st day followed by 5 mg/kg/dose in the 2nd and 3rd days with follow up echo was done after finishing the course paracetamol was given as 15 mglkg/6 hrs for three days with follow up echo to check the ductal closure.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
30
Inclusion Criteria
  1. Gestational age ≤ 35 weeks
  2. Aged 2-7 days with color Doppler echocardiographic evidence of PDA
  3. Urine output more than 1 ml/kg/hr
  4. Creatinine concentration level less than 1.8 mg/dl
Exclusion Criteria

Neonates who have one or more of the following criteria were excluded from the study:

  1. Congenital heart diseases of any type including

    • Pulmonary stenosis
    • Anomalus in pulmonary venous drainage
    • Ventricular septal defect
  2. Major congenital anomalies as hydrops fetalis

  3. Low platelets count (less than 60, 000/mm3)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ibuprofen groupibuprofentreatment of pda with oral ibuprofen with a loading dose 10 mg/kg/ds in the first day followed by 5 mg/kg/ds in the second ant third days then a follow up echo is done
paracetamol groupparacetamoltreatment of pda with oral paracetamol with dose of 15 mg/kg/ds every 6 hours for 3 days then a follow up echo is done
Primary Outcome Measures
NameTimeMethod
closure of PDA6 days

Echo confirmed closure

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath